Skip to main content
NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
RT

Relay Therapeutics, Inc. (RLAY)

NASDAQ • Healthcare

$18.66
-$0.44 (-2.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$18.76
Previous Close$18.66
Day Range$18.54 - $19.18
Avg. Volume (3M)2.6M
Market Cap$4.1B
52 Week Range
$3.89$21.27
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$350K100%
Gross Profitminus cost of goods$350K100%

Fundamentals & Financials

Revenue (TTM)
$10.3M
Net Income (TTM)
-$286M
EPS (TTM)
-$1.57
ROA (TTM)
-29.57%
Current Ratio
18.27

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.8%Q1 2026-$0.32
-17.1%Q2 2026-$0.41
-4.8%Q3 2026-$0.41
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -4.8%

Relay Therapeutics missed EPS expectations in the second fiscal quarter of 2026, reporting on Aug. 6 based on preliminary results, with a loss of $0.41 per share versus a $0.39 loss estimate, 4.8% below consensus. The company posted about $350,000 of gross profit, but operating income was a loss of $90.8 million and operating cash flow was negative $105.2 million. Net loss came in at about $83.7 million, widening 18.9% from roughly $70.4 million a year ago.

View full earnings history

About Relay Therapeutics, Inc.

Relay Therapeutics, Inc. is a NASDAQ-listed biotechnology company that develops small molecule therapies for cancer and genetic conditions through a precision-medicine approach and clinical trials. In FY2025, Relay Therapeutics generated $15.4 million in revenue. The company, formerly known as Allostery, Inc., is based in Cambridge, Massachusetts, was founded in 2015, and went public in 2020.

Name
Relay Therapeutics, Inc.
CEO
Sanjiv K. Patel
Website
www.relaytx.com
Industry
Healthcare
Year Founded
2015
Employees
202

Today's Snapshot

AI-generated

So far today, RLAY is trading 1% higher at 18.84, while its sector was flat. Relay Therapeutics executives sold shares under a prearranged trading plan.

Trading Volume

Below 10d avg (2.9M)

768.5K

vs S&P 500 Today

Outperforming Market

+1.52%

Updated: September 10, 2026 at 17:06 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
RLAY is exhibiting a cautious downward bias as short-term momentum and trend measures conflict: MACD and the ten‑period momentum are negative while intraday VWAP and on‑balance volume are supportive, suggesting recent buying interest. Price sits roughly at 19 but remains under several medium moving averages even as longer‑term averages are well below, and ADX indicates only limited trend strength. Volatility is modest by ATR, which points to contained price swings. Technical takeaway: Sell — negative momentum and weak trend strength outweigh intraday VWAP/OBV support.
All signals
  • EMA (5 indicators)$13.60 - $19.18
    Buy
  • RSI (14)47.09
    Neutral
  • Stochastic %K (14, 3, 3)31.27
    Neutral
  • MACD Level (12, 26)-0.14
    Sell

Peers & Related Assets

AMLXAmylyx Pharmaceuticals, Inc.
$32.4-4.4%
ZBIOZenas BioPharma, Inc.
$32.29-2.3%
SNDXSyndax Pharmaceuticals, Inc.
$19.84-0.5%
INBXInhibrx Biosciences Inc.
$112.86-1.3%
ORICORIC Pharmaceuticals, Inc.
$12.5-0.9%
SANASana Biotechnology, Inc.
$3.17-8.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.